Emletra is a combination HIV medicine.
It contains two drugs in one tablet:

• Emtricitabine (FTC)

• Tenofovir alafenamide (TAF)

It is usually used with another HIV medicine (like an integrase inhibitor) as part of a complete HIV treatment regimen.

Mechanism 

• Both Emtricitabine and Tenofovir alafenamide block the HIV enzyme reverse transcriptase, which the virus needs to make copies of itself.

• This prevents HIV from multiplying.

• As a result, the virus level in the blood goes down, and the immune system becomes stronger.

  Uses

  • Treatment of HIV-1 infection in adults and adolescents (as part of combination therapy).

  • Sometimes used for HIV prevention (PrEP – pre-exposure prophylaxis) in people at high risk, under doctor supervision.

    Adverse Effects 

    Common side effects:

    • Headache

    • Nausea, stomach upset

    • Tiredness

    • Diarrhea